D K Whynes

959 total citations
26 papers, 728 citations indexed

About

D K Whynes is a scholar working on Oncology, Economics and Econometrics and General Health Professions. According to data from OpenAlex, D K Whynes has authored 26 papers receiving a total of 728 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 10 papers in Economics and Econometrics and 6 papers in General Health Professions. Recurrent topics in D K Whynes's work include Colorectal Cancer Screening and Detection (10 papers), Global Cancer Incidence and Screening (7 papers) and Healthcare Policy and Management (6 papers). D K Whynes is often cited by papers focused on Colorectal Cancer Screening and Detection (10 papers), Global Cancer Incidence and Screening (7 papers) and Healthcare Policy and Management (6 papers). D K Whynes collaborates with scholars based in United Kingdom, Australia and Canada. D K Whynes's co-authors include J H Scholefield, Jane Wolstenholme, C M Mangham, Sue Moss, J D Hardcastle, J D Hardcastle, Emma Frew, Andrew Walker, J D Hardcastle and George Bouliotis and has published in prestigious journals such as Gut, British Journal of Cancer and British journal of surgery.

In The Last Decade

D K Whynes

26 papers receiving 703 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D K Whynes United Kingdom 13 455 293 193 154 115 26 728
Emily S. Pavey United States 13 275 0.6× 193 0.7× 213 1.1× 105 0.7× 82 0.7× 23 765
H.S. Snijders Netherlands 18 727 1.6× 257 0.9× 564 2.9× 58 0.4× 42 0.4× 30 994
Elena Cabeza Spain 15 512 1.1× 169 0.6× 111 0.6× 282 1.8× 43 0.4× 30 884
Zhaomin Xu United States 18 487 1.1× 136 0.5× 500 2.6× 51 0.3× 44 0.4× 53 892
Melissa Rich United States 5 549 1.2× 300 1.0× 163 0.8× 211 1.4× 41 0.4× 8 689
Mary C. Schroeder United States 15 333 0.7× 150 0.5× 108 0.6× 168 1.1× 83 0.7× 61 801
Kathleen Decker Canada 17 677 1.5× 99 0.3× 83 0.4× 61 0.4× 73 0.6× 77 989
James Grana United States 13 244 0.5× 138 0.5× 74 0.4× 61 0.4× 153 1.3× 16 568
Saurabh Nagar United States 16 113 0.2× 376 1.3× 80 0.4× 91 0.6× 97 0.8× 62 775
Barbara‐Ann Adelstein Australia 14 358 0.8× 135 0.5× 125 0.6× 145 0.9× 14 0.1× 27 611

Countries citing papers authored by D K Whynes

Since Specialization
Citations

This map shows the geographic impact of D K Whynes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D K Whynes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D K Whynes more than expected).

Fields of papers citing papers by D K Whynes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D K Whynes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D K Whynes. The network helps show where D K Whynes may publish in the future.

Co-authorship network of co-authors of D K Whynes

This figure shows the co-authorship network connecting the top 25 collaborators of D K Whynes. A scholar is included among the top collaborators of D K Whynes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D K Whynes. D K Whynes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duffy, SW, James Mackay, Susan N. Thomas, et al.. (2013). Evaluation of mammographic surveillance services in women aged 40–49 years with a moderate family history of breast cancer: a single-arm cohort study. Health Technology Assessment. 17(11). vii–xiv, 1. 12 indexed citations
2.
Scholefield, J H, Sue Moss, C M Mangham, D K Whynes, & J D Hardcastle. (2011). Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up. Gut. 61(7). 1036–1040. 212 indexed citations
3.
Whynes, D K, et al.. (2008). Management of low‐grade cervical abnormalities detected at screening: which method do women prefer?. Cytopathology. 19(6). 355–362. 12 indexed citations
4.
Frew, Emma, Jane Wolstenholme, & D K Whynes. (2005). Eliciting relative preferences for two methods of colorectal cancer screening. European Journal of Cancer Care. 14(2). 124–131. 15 indexed citations
5.
Whynes, D K, et al.. (2003). Colorectal cancer, screening and survival: the influence of socio-economic deprivation. Public Health. 117(6). 389–395. 77 indexed citations
6.
Sach, Tracey, et al.. (2003). EVIDENCE OF IMPROVING COST-EFFECTIVENESS OF PEDIATRIC COCHLEAR IMPLANTATION. International Journal of Technology Assessment in Health Care. 19(2). 421–431. 12 indexed citations
8.
Wolstenholme, Jane & D K Whynes. (1999). The hospital costs of treating lung cancer in the United Kingdom. British Journal of Cancer. 80(1-2). 215–218. 43 indexed citations
9.
Whynes, D K. (1999). Cost-effectiveness of faecal occult blood screening for colorectal cancer: results of the Nottingham trial. Critical Reviews in Oncology/Hematology. 32(2). 155–165. 10 indexed citations
10.
Rodgers, Sarah, Anthony Avery, David Meechan, et al.. (1999). Controlled trial of pharmacist intervention in general practice: the effect on prescribing costs.. PubMed. 49(446). 717–20. 33 indexed citations
11.
Wolstenholme, Jane & D K Whynes. (1998). Stage-specific treatment costs for cervical cancer in the United Kingdom. European Journal of Cancer. 34(12). 1889–1893. 49 indexed citations
12.
Whynes, D K, et al.. (1997). Symptoms before and after surgery for colorectal cancer. Quality of Life Research. 6(1). 61–66. 25 indexed citations
13.
Whynes, D K, et al.. (1997). GP fundholding and the costs of prescribing: further results. Journal of Public Health. 19(1). 18–22. 16 indexed citations
14.
Baines, Darrin & D K Whynes. (1997). Over-the-counter drugs and prescribing in general practice.. PubMed. 47(417). 221–4. 8 indexed citations
15.
Whynes, D K. (1995). Optimal times of transfer between therapies: A mathematical framework. Journal of Health Economics. 14(4). 477–490. 3 indexed citations
16.
Moss, Susan, et al.. (1995). Effect of Retesting with Dietary Restriction in Haemoccult Screening for Colorectal Cancer. Journal of Medical Screening. 2(1). 41–44. 11 indexed citations
17.
Whynes, D K, Aileen Neilson, Michael H. Robinson, & J D Hardcastle. (1994). Colorectal cancer screening and quality of life. Quality of Life Research. 3(3). 191–198. 41 indexed citations
18.
Whynes, D K, Andrew Walker, & J D Hardcastle. (1992). Effect of subject age on costs of screening for colorectal cancer.. Journal of Epidemiology & Community Health. 46(6). 577–581. 13 indexed citations
19.
Whynes, D K. (1991). When the future is in futures.. PubMed. 101(5246). 14–5. 1 indexed citations
20.
Walker, Andrew, D K Whynes, & J D Hardcastle. (1991). Rehydration of Guaiac-Based Faecal Occult Blood Tests in Mass Screening for Colorectal Cancer: An Economic Perspective. Scandinavian Journal of Gastroenterology. 26(2). 215–218. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026